Clark B. Jefferson

CIK 00014353882 companiesCARY, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001435388

Recent Transactions

50 trades

Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2015-05-11$0.27/sh−50,000→ 13,139,215 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2015-01-20$0.35/sh−5,500→ 12,181,395 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2015-01-14$0.35/sh−153,467→ 12,186,895 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2015-01-13$0.35/sh−14,000→ 12,340,362 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2015-01-12$0.35/sh−73,496→ 12,354,362 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2015-01-09$0.35/sh−15,850→ 13,189,215 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2015-01-09$0.35/sh−61,037→ 12,427,858 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2015-01-08$0.35/sh−82,850→ 12,488,895 total
Award
Tobira Therapeutics, Inc.
Common Stock (right to buy)
2015-01-01+159,261→ 159,261 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2014-12-31$0.35/sh−100→ 12,571,745 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2014-12-30$0.35/sh−299,900→ 12,571,845 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2014-12-30$0.35/sh−1,200→ 13,205,065 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2014-12-29$0.35/sh−100→ 12,871,745 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2014-12-22$0.37/sh−10,300→ 12,871,845 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2014-12-19$0.35/sh−97,150→ 12,882,145 total
Sale
Nuo Therapeutics, Inc.$AURX
Common Stock
2014-11-28$0.35/sh−2,850→ 12,979,295 total
Other
Nuo Therapeutics, Inc.$AURX
Common Stock
2014-11-11$1.18/sh+1,270,000→ 13,206,265 total
Exercise of In-Money
Tobira Therapeutics, Inc.
Stock Option (right to buy)
2014-02-20−1→ 0 total
Exercise of In-Money
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-02-20$3.34/sh+2,095→ 1,116,854 total
Exercise of In-Money
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-02-20$4.51/sh+3,341→ 1,125,642 total
Exercise of In-Money
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-02-20$4.51/sh+5,447→ 1,122,301 total
Exercise of In-Money
Tobira Therapeutics, Inc.
Warrant (right to buy)
2014-02-20−1→ 0 total
Exercise of In-Money
Tobira Therapeutics, Inc.
Stock Option (right to buy)
2014-02-20−1→ 0 total
Exercise of In-Money
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2014-02-20$0.17/sh+4,491→ 1,130,133 total
Exercise of In-Money
Tobira Therapeutics, Inc.
Stock Option (right to buy)
2014-02-20−1→ 0 total
Award
Tobira Therapeutics, Inc.
Stock Option (right to buy)
2014-01-01+9,640→ 9,640 total
Conversion
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2013-08-27+321,973→ 707,087 total
Conversion
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2013-08-27+145,411→ 164,722 total
Conversion
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2013-08-27+133,067→ 385,114 total
Award
Tobira Therapeutics, Inc.
Stock Option (right to buy)
2013-08-27+17,964→ 17,964 total
Conversion
Tobira Therapeutics, Inc.
Series E Preferred Stock
2013-08-27−807,652→ 0 total
Conversion
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2013-08-27+87,325→ 252,047 total
Conversion
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2013-08-27+48,362→ 755,449 total
Conversion
Tobira Therapeutics, Inc.
Series C Preferred Stock
2013-08-27−2,222,222→ 0 total
Conversion
Tobira Therapeutics, Inc.
Series D Preferred Stock
2013-08-27+5,376,964→ 0 total
Conversion
Tobira Therapeutics, Inc.
Series A Preferred Stock
2013-08-27−2,428,367→ 0 total
Purchase
Tobira Therapeutics, Inc.
Common Stock, par value $0.001 per share
2013-08-27$4.00/sh+359,310→ 1,114,759 total
Conversion
Tobira Therapeutics, Inc.
Series B Preferred Stock
2013-08-27−1,458,333→ 0 total
Other
Nuo Therapeutics, Inc.$AURX
Common Stock
2013-06-13−105,300→ 11,936,265 total
Purchase
Nuo Therapeutics, Inc.$AURX
Common Stock
2013-02-22$0.55/sh+90,909→ 175,533 total
Purchase
Nuo Therapeutics, Inc.$AURX
Common Stock
2013-02-22$0.55/sh+32,238→ 157,276 total
Purchase
Nuo Therapeutics, Inc.$AURX
Common Stock
2013-02-22$0.55/sh+18,182→ 60,494 total
Purchase
Nuo Therapeutics, Inc.$AURX
Common Stock
2013-02-22$0.55/sh+90,909→ 429,404 total
Purchase
Nuo Therapeutics, Inc.$AURX
Warrant (right to buy)
2013-02-22+22,567→ 22,567 total
Purchase
Nuo Therapeutics, Inc.$AURX
Warrant (right to buy)
2013-02-22+15,616→ 15,616 total
Purchase
Nuo Therapeutics, Inc.$AURX
Warrant (right to buy)
2013-02-22+63,636→ 63,636 total
Purchase
Nuo Therapeutics, Inc.$AURX
Warrant (right to buy)
2013-02-22+12,727→ 12,727 total
Purchase
Nuo Therapeutics, Inc.$AURX
Common Stock
2013-02-22$0.55/sh+22,308→ 108,830 total
Purchase
Nuo Therapeutics, Inc.$AURX
Common Stock
2013-02-22$0.55/sh+27,273→ 39,967 total
Purchase
Nuo Therapeutics, Inc.$AURX
Warrant (right to buy)
2013-02-22+63,636→ 63,636 total

Companies

Recent Filings

Address

790 SE CARY PARKWAY, SUITE 204

CARY, NC, 27511

View on SEC.gov